dismiss

Webinar : L'évolution du service de l'équipement /Apprenez plus/registre

Other Headlines

Leading job search engine provides notable data.
The American College of Radiology announced it will be among the first to apply for authority to accredit freestanding diagnostic imaging centers as required by new CMS rules.
Future-focused performance management system prepares hospital leaders for the changing health care environment.
Workgroup advises the Office of the National Coordinator for Health IT (ONC).
Honor bestowed at the 28th International Congress on Applications of Lasers and Electro-Optics (ICALEO®).

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More People & Company Headlines

Chairman Rockefeller Sends Open Letter to CIGNA on Insurance Practices Letter critical of industry medical loss ratio information.

TriMedx to Join Pre-RSNA Webinar on Equipment Service -- You're Invited to Attend "The Evolution of Equipment Service: How to Navigate Through Tough Financial Times" will be hosted by DOTmed on Nov. 18th. Sponsored by ReMedPar.

ASTRO: Hologic MammoSite Radiation Therapy Keeps Cancer From Recurring Breast cancer patients treated with Hologic's MammoSite radiation therapy system experienced less than a 4% rate of recurring cancer after five years.

This Month in Medical History: Facing the World Again A face transplant transformed surgery in November 2005.

MEDICA 2009 Preview The 41st World Forum for Medicine International Trade Fair with Congress will be held November 18-21, 2009 in Dusseldorf, Germany.

Stryker Biotech and Management Charged With Fraudulent Marketing Scheme Company accused of promoting unauthorized mixture of OP-1 and Calstrux for invasive surgeries.

Merck and Schering-Plough Merge Second recent blockbuster pharma fuse.

Focus on Performance: What to Do About Regulation? A columnist weighs in from DOTmed Business News.

Recall: Cordis CROSSOVER Sheath Introducer Attention: Interventional radiological healthcare professionals, hospital risk managers.

Leasing as the Bridge over Troubled Waters Credit crunch leads to looking at leasing options for practices.

The company's disc arthroplasty
system for the cervical
spine is receiving attention

(click to enlarge)

Medtronic's Bryan® Cervical Disc System to Be Reviewed by FDA Panel

by Barbara Kram, Editor
MEMPHIS, Tenn. - Medtronic, Inc. (NYSE: MDT) recently announced the Bryan® Cervical Disc System will be reviewed by the U.S. Food and Drug Administration's (FDA) Orthopedic and Rehabilitation Devices advisory panel on July 17, 2007.

William Hawkins, president and chief operating officer, made the announcement during Medtronic's fourth quarter earnings conference call on Tuesday, May 22. If the panel votes to recommend approval, the FDA will consider this vote when deciding on full approval. The Bryan Cervical Disc System is the second disc arthroplasty system for the cervical spine to be reviewed by an FDA panel. The first, Medtronic's Prestige® Cervical Disc, is currently under evaluation by the FDA with expected approval later this summer.

The Bryan Cervical Disc is designed to alleviate pain and preserve motion and flexibility while replacing a diseased disc that is removed from a patient's cervical spine. Traditionally, the most common form of surgery for treating cervical degenerative disc disease (DDD) is cervical spine fusion. More than 200,000 cervical procedures are performed each year to relieve compression on the spinal cord or nerve roots and to implant a metal plate to rigidly fuse the vertebrae together.

The Bryan Cervical Disc underwent a multi-center prospective, randomized, controlled, equivalency clinical trial to assess the safety and effectiveness based on comparisons between data collected from 463 skeletally mature patients with single level symptomatic cervical DDD at one level between C3-C7. The investigational group of 242 patients was implanted with the Bryan Cervical Disc, while the control group of 221 patients received a single level anterior interbody fusion procedure with allograft and plate stabilization.

In the clinical trial, cervical DDD was defined as a combination of the following: disc herniation with radiculopathy, spondylotic radiculopathy, disc herniation with myelopathy, or spondylotic myelopathy.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED